• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎儿及新生儿溶血病——免疫血液学视角

Hemolytic disease of the fetus and newborn-a perspective of immunohematology.

作者信息

Rodrigues Mirelen Moura de Oliveira, Mattos Denise, Almeida Silvana, Fiegenbaum Marilu

机构信息

Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil; Grupo Hospitalar Conceição (GHC), Serviço de Hemoterapia, Porto Alegre, RS, Brazil.

Grupo Hospitalar Conceição (GHC), Serviço de Hemoterapia, Porto Alegre, RS, Brazil.

出版信息

Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S246-S257. doi: 10.1016/j.htct.2024.04.122. Epub 2024 Aug 18.

DOI:10.1016/j.htct.2024.04.122
PMID:39242288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670614/
Abstract

BACKGROUND

Hemolytic disease of the fetus and newborn is a public health problem caused by maternal-fetal incompatibility; no prophylaxis is available for most alloantibodies that induce this disease. This study reviews the literature regarding which antibodies are the most common in maternal plasma and which were involved in hemolytic disease of the fetus and newborn.

METHOD

Seventy-five studies were included in this review using a systematic search. Two independent authors identified studies of interest from the PubMed and SciELO databases.

MAIN RESULTS

Forty-four case reports were identified, of which 11 babies evolved to death. From 17 prevalence studies, the alloimmunization rate was 0.17 % with 161 babies receiving intrauterine transfusions and 23 receiving transfusions after birth. From 28 studies with alloimmunized pregnant women (7616 women), 455 babies received intrauterine transfusions and 21 received transfusions after birth.

CONCLUSION

Rh, Kell, and MNS were the commonest blood systems involved. The geographical distribution of studies shows that as these figures vary between continents, more studies should be performed in different countries. Investing in early diagnosis is important to manage the risks and complications of hemolytic disease of the fetus and newborn.

摘要

背景

胎儿和新生儿溶血病是由母胎血型不合引起的公共卫生问题;对于大多数引发该病的同种抗体,尚无预防措施。本研究回顾了有关哪些抗体在母体血浆中最为常见以及哪些与胎儿和新生儿溶血病有关的文献。

方法

本综述通过系统检索纳入了75项研究。两名独立作者从PubMed和SciELO数据库中识别出感兴趣的研究。

主要结果

共识别出44例病例报告,其中11名婴儿死亡。在17项患病率研究中,同种免疫率为0.17%,161名婴儿接受了宫内输血,23名婴儿出生后接受了输血。在28项针对同种免疫孕妇(7616名妇女)的研究中,455名婴儿接受了宫内输血,21名婴儿出生后接受了输血。

结论

Rh、Kell和MNS是最常涉及的血型系统。研究的地理分布表明,由于这些数字在各大洲之间存在差异,不同国家应开展更多研究。投资于早期诊断对于管理胎儿和新生儿溶血病的风险及并发症至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d5/11670614/6148c5ee38bc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d5/11670614/ff0e33e17160/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d5/11670614/6148c5ee38bc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d5/11670614/ff0e33e17160/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4d5/11670614/6148c5ee38bc/gr2.jpg

相似文献

1
Hemolytic disease of the fetus and newborn-a perspective of immunohematology.胎儿及新生儿溶血病——免疫血液学视角
Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S246-S257. doi: 10.1016/j.htct.2024.04.122. Epub 2024 Aug 18.
2
Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.由于宫内输血,胎儿和新生儿溶血病中代偿性红细胞生成的抑制。
Am J Obstet Gynecol. 2020 Jul;223(1):119.e1-119.e10. doi: 10.1016/j.ajog.2020.01.028. Epub 2020 Jan 21.
3
Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.1996年至2010年美国胎儿及新生儿溶血病的活产患病率。
AJOG Glob Rep. 2023 Mar 24;3(2):100203. doi: 10.1016/j.xagr.2023.100203. eCollection 2023 May.
4
Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunization.恒河猴抗原同种免疫所致胎儿及新生儿溶血病严重程度的特征分析。
AJOG Glob Rep. 2025 Jan 9;5(1):100439. doi: 10.1016/j.xagr.2024.100439. eCollection 2025 Feb.
5
Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review.拉丁美洲国家的胎儿和新生儿溶血病及恒河猴同种免疫:一项范围综述
BMC Pregnancy Childbirth. 2024 Dec 20;24(1):830. doi: 10.1186/s12884-024-07044-3.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.胎儿和新生儿溶血病:产前全景的系统文献回顾。
BMC Pregnancy Childbirth. 2023 Jan 7;23(1):12. doi: 10.1186/s12884-022-05329-z.
8
Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.预测抗 Kell 介导的胎儿和新生儿溶血病:实验室管理的诊断准确性。
Am J Obstet Gynecol. 2018 Oct;219(4):393.e1-393.e8. doi: 10.1016/j.ajog.2018.07.020. Epub 2018 Jul 29.
9
Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.以色列的红细胞同种免疫发生率及胎儿和新生儿溶血病:一项回顾性研究。
Transfusion. 2020 Nov;60(11):2684-2690. doi: 10.1111/trf.15987. Epub 2020 Aug 8.
10
The management of hemolytic disease in the fetus and newborn.胎儿及新生儿溶血病的管理
Semin Perinatol. 1997 Feb;21(1):39-44. doi: 10.1016/s0146-0005(97)80018-3.

本文引用的文献

1
Hemolytic Disease of the Fetus and Newborn Due to Anti-Gonzales Antibody.胎儿及新生儿因抗冈萨雷斯抗体所致的溶血病
Cureus. 2023 Mar 29;15(3):e36860. doi: 10.7759/cureus.36860. eCollection 2023 Mar.
2
Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia.RhD致敏孕妇的围产期结局:埃塞俄比亚一家三级护理医院的五年横断面研究
Int J Womens Health. 2023 Apr 12;15:571-578. doi: 10.2147/IJWH.S402373. eCollection 2023.
3
Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
抗RH1同种免疫:母体抗体达到何种阈值会有严重胎儿贫血的风险?
Transfusion. 2023 Mar;63(3):629-637. doi: 10.1111/trf.17264. Epub 2023 Feb 3.
4
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems.国际输血协会红细胞免疫遗传学和血型术语工作组关于巴塞尔及三次虚拟业务会议的报告:血型系统更新。
Vox Sang. 2022 Nov;117(11):1332-1344. doi: 10.1111/vox.13361. Epub 2022 Sep 19.
5
Fetal and Neonatal Reticulocyte Count Response to Intrauterine Transfusion for the Treatment of Red Blood Cell Alloimmunization.胎儿和新生儿网织红细胞计数对宫内输血治疗红细胞同种免疫的反应。
J Pediatr Hematol Oncol. 2022 Nov 1;44(8):e1046-e1049. doi: 10.1097/MPH.0000000000002450. Epub 2022 Mar 30.
6
Maternal mirror syndrome with foetal hydrops due to isoimunization by anti-KPa antibodies: A case report and narrative literature review.抗KPa抗体同种免疫所致胎儿水肿的母体镜像综合征:一例报告及文献综述
Clin Case Rep. 2022 Feb 16;10(2):e05484. doi: 10.1002/ccr3.5484. eCollection 2022 Feb.
7
Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.抗 K 和抗 D 引起的母体红细胞同种免疫的母婴结局预测因子与宫内输血治疗。
Br J Haematol. 2022 Feb;196(4):1096-1104. doi: 10.1111/bjh.17956. Epub 2021 Dec 4.
8
Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.新生儿一过性先天性胰岛素过多症和溶血病,尽管进行了 RhD 预防:病例报告。
J Med Case Rep. 2021 Nov 26;15(1):573. doi: 10.1186/s13256-021-03167-9.
9
The combined effect of anti-D and non-D Rh antibodies in maternal alloimmunization.抗-D和非-D Rh抗体在母体同种免疫中的联合作用。
Turk J Obstet Gynecol. 2021 Sep 27;18(3):181-189. doi: 10.4274/tjod.galenos.2021.68822.
10
Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.孕期红细胞抗体的管理及临床后果:一项基于人群的队列研究。
Acta Obstet Gynecol Scand. 2021 Dec;100(12):2216-2225. doi: 10.1111/aogs.14261. Epub 2021 Sep 2.